Email this article A real way of reducing coronary heart disease mortality in Russia
- Authors: Aronov D.M1, Bubnova M.G1
-
Affiliations:
- State Research Center of Preventive Medicine, Ministry of Health and Social Development of the Russian Federation
- Issue: Vol 1, No 1 (2010)
- Pages: 11-17
- Section: Articles
- URL: https://journal-vniispk.ru/2221-7185/article/view/44951
- DOI: https://doi.org/10.26442/CS44951
- ID: 44951
Cite item
Full Text
Abstract
The paper analyzes reasons for high cardiovascular mortality in Russia and states that therapeutic work done by primary practitioners is ineffective. It gives the statistical data of the European Union, the USA, and some other countries where overmortality from cardiovascular diseases has been overcome by the governmental cardiovascular prevention and rehabilitation system. It is concluded that the experience of these countries can be applied to reduce cardiovascular overmortality in Russia
Full Text
##article.viewOnOriginalSite##About the authors
D. M Aronov
State Research Center of Preventive Medicine, Ministry of Health and Social Development of the Russian Federationд-р мед. наук, проф., руководитель отдела ФГУ ГНИЦ профилактической медицины МЗ РФ
M. G Bubnova
State Research Center of Preventive Medicine, Ministry of Health and Social Development of the Russian Federation
Email: mbubnova@gnicPM.ru
д-р мед. наук, проф.
References
- Аронов Д.М. и др. Результаты санаторной реабилитации больных инфарктом миокарда. Тер. арх. 1983; 1: 33–8.
- Оганов Р.Г., Масленникова Г.Я. Смертность от сердечно - сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения в России. Кардиоваскул. тер. и вторичная профилак. 2003; 1 (3): 5–7.
- Оганов Р.Г. и др. Особенности диагностики и терапии стабильной стенокардии в Российской Федерации (Международное исследование ATP – Angina Treatment Pottern). Кардиология. 2003; 5: 9–15.
- Шхвацабая И.К., Аронов Д.М., Зайцев В.П. Реабилитация больных ишемической болезнью сердца. М.: Медицина, 1978.
- Antithrombotic Trialists’ Collaboration, «Collaborative meta - analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients». BMJ 2002; 324 (7329): 71–86.
- Berger J.S., Roncaglioni M.C., Avanzini F et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex - specific meta - analysis of randomized controlled trials. JAMA 2006; 295 (3): 306–13.
- de Gaetano G. Collaborative Group of the Primary Prevention Project. Low - dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001; 357 (9250): 89–95.
- Pasquali S.K. et al. Am J Cardiol 2001; 88: 1415–6.
- Ridker P.M., Cook N.R., Lee I.M., Gordon D et al. A randomized trial of low - dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352 (13): 1293–304.
- Taylor R.S. et al. Exercise - based rehabilitation for patients with coronary heart disease: review and metaanalysis of randomized controlled trials. Am J Med 2004; 116: 10.
- WHO Expert Committee. Rehabilitation after cardiovascular diseases, with special emphasis on developing countries. Geneva, 1993.
Supplementary files
